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Abstract
Background: Studies on the myotonic dystrophy protein kinase (DMPK) gene and gene products have thus far mainly
concentrated on the fate of length mutation in the (CTG)n repeat at the DNA level and consequences of repeat expansion at
the RNA level in DM1 patients and disease models. Surprisingly little is known about the function of DMPK protein products.
Methodology/Principal Findings: We demonstrate here that transient expression of one major protein product of the
human gene, the hDMPK A isoform with a long tail anchor, results in mitochondrial fragmentation and clustering in the
perinuclear region. Clustering occurred in a variety of cell types and was enhanced by an intact tubulin cytoskeleton. In
addition to morphomechanical changes, hDMPK A expression induces physiological changes like loss of mitochondrial
membrane potential, increased autophagy activity, and leakage of cytochrome c from the mitochondrial intermembrane
space accompanied by apoptosis. Truncation analysis using YFP-hDMPK A fusion constructs revealed that the protein’s tail
domain was necessary and sufficient to evoke mitochondrial clustering behavior.
Conclusion/Significance: Our data suggest that the expression level of the DMPK A isoform needs to be tightly controlled
in cells where the hDMPK gene is expressed. We speculate that aberrant splice isoform expression might be a
codetermining factor in manifestation of specific DM1 features in patients.
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Introduction
The myotonic dystrophy protein kinase (DMPK) gene is involved
in myotonic dystrophy type I (DM1) when it is mutant and
contains an unstable (CTG)n segment in its 39 terminal exon [1].
DMPK encodes several serine/threonine protein kinases, believed
to be involved in ion homeostasis and remodeling of the actin
cytoskeleton [2–5]. Up till now, emphasis in most DM1 studies
was on the pathobiological significance of toxic RNA products
from the mutant DMPK gene. Only relatively few studies have
addressed individual protein products from the DMPK gene,
including their normal structure function relationship [6,7].
Constitutive and regulated modes of alternative splicing exist for
DMPK pre-mRNA and result in the expression of six major
DMPK splice isoforms, conserved between mouse and man.
Individual isoforms are characterized by presence of either one of
two types of long C-termini (tail versions 1 or 2; DMPK isoforms A
to D) or a rather short C-terminus (tail 3; isoforms E and F),
combined with absence or presence of an internal VSGGG-motif
(A vs B, C vs D, E vs F) [5]. DMPK isoforms A–D are typical tail-
anchored proteins with a membrane segment in their C-terminus.
These isoforms are mainly expressed in heart, skeletal muscle and
brain. Isoforms E and F are cytosolic proteins, predominantly
found in smooth muscle cells [2,5,8].
Previously, we demonstrated that tail anchors in DMPK A/B
and DMPK C/D drive binding to specific organellar membranes
[9]. In mouse, this results in binding of mDMPK A and B to the
endoplasmic reticulum (ER) and in binding of mDMPK C (and D)
to the mitochondrial outer membrane (MOM). In humans,
hDMPK A/B and C/D have also distinct tails, but these isoforms
all anchor to the MOM. Isoform hDMPK A is unique in that its
transient expression causes mitochondrial morphology to become
abnormal, eventually leading to cell death via an as yet
unidentified mechanism [10].
Mitochondria form an elaborate network with variable
morphology and spatial distribution, tightly controlled by the
physiological state of the cell and dependent on cell type and
metabolic needs [11]. Organellar form and function in this
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on the internal distribution of energy metabolites, the mode of
sequestration of intracellular Ca
2+ ions [12] and perhaps even
apoptosis signaling [13]. MOM-associated proteins like mitofusins
1 and 2 (Mfn1 and 2) and OPA1 or hFis control mitochondrial
fragmentation or perinuclear localization [14–17].
Various diseases, either coupled to acquired or inherited defects
in bioenergetic circuits or to abnormalities in the fission-fusion
machinery have been associated with abnormal mitophysiology
[18]. Also in DM1 patients, abnormal mitochondrial form and
mitochondrial dysfunction have been described [19,20]. Further-
more, overexpression of RNA and protein products from a
hDMPK (CTG)11 transgene in a DM1 mouse model induced
accumulation of mitochondria in the subsarcolemmal space and
formation of aberrant cristae and caused a reduced workload
tolerance in mice [21].
Quantitative and qualitative aspects of DMPK biology—via
mitochondrial involvement—could thus contribute to typical
features of DM1 disease manifestation, including defective Ca
2+
ion homeostasis, insulin resistance and loss of cell viability in
muscle, brain and other organs [7]. Here we report on one aspect,
consequences of expression of the hDMPK A isoform, in
particular its binding to the MOM. By use of transfection-
complementation experiments in cultured cells, with or without
DMPK deficiency, we analyze hDMPK A’s role in determining
mitochondrial fate and function and the functional integrity of the
cell. We demonstrate that the protein’s C-terminal tail is sufficient
for induction of perinuclear clustering. Microscopy and biochem-
ical analysis revealed that mitochondrial clustering was associated
with increased autophagic activity. Ultimately, decoration of
mitochondria with hDMPK A results in loss of cell-functional
integrity and in the initiation of apoptosis.
Results
The tail region of hDMPK A is responsible for perinuclear
mitochondrial clustering
Earlier, we had observed that hDMPK A has the capacity to
localize to the MOM and affect mitochondrial distribution in a
broad range of cell lines [10]. To analyze quantitative and
qualitative aspects of this phenomenon in more detail, we used
transfection of C2C12 myoblasts, a natural host cell line for DMPK
proteins [8]. Transfection of YFP-hDMPK A resulted in
mitochondrial decoration in ,60% of all YFP-positive cells, while
for the remaining ,40% a cytosolic fluorescence without
mitochondrial binding was observed. In contrast, mitochondrial
YFP-fluorescence was found in virtually all cells that expressed
YFP-hDMPK C. Classification of cells with MOM-bound
hDMPK A (see Figure 1A for morphological classes) revealed
that the majority of cells contained mitochondria with a clustered
appearance (Figure 1B). Approximately 25% possessed fragment-
ed mitochondria and only few showed a network of normal,
elongated mitochondria. Frequencies in the different categories
varied somewhat with experimental conditions, including trans-
fection dose and duration (data not shown). Virtually all
mitochondria in cells with cytosolic YFP-hDMPK A displayed a
normal elongated appearance (Figure 1A, lowest panel), similar to
cells with MOM-bound YFP-hDMPK C or mock-transfected
cells. Taken together, these observations suggest that mitomor-
phological changes are only induced in cells where hDMPK A
proteins are associated to mitochondria.
To investigate whether the entire protein or only domains of
hDMPK A are involved in this phenomenon, a series of YFP-
fusion constructs was designed (Figure 1C) and expressed in C2C12
myoblasts (Figure 1D). Tagging with monomeric L221K YFP
variant was incorporated to exclude involvement of the dimerizing
capacity of the YFP portion [9]. Use of this monomeric YFP tag
did not affect hDMPK A’s mitochondrial clustering behavior,
demonstrating that this is indeed an intrinsic property of the
DMPK moiety itself (Figure 1D). Importantly, mitochondrial
clustering was still observed when the kinase-dead K100A mutant
was expressed (Figure 1D), consistent with the idea that enzymatic
activity is not required. Since hDMPK C also anchors at
mitochondria but does not change mitochondrial morphology,
even though it differs from hDMPK A only in the C terminus [10],
we hypothesized that the tail domain must be responsible for
mitochondrial clustering. Indeed, expression of mutant YFP-
hDMPK A
(534–629) confirmed that clustering capacity was entirely
contained within hDMPK A’s C-terminus (Figure 1D).
It is well known that the 39 UTR of a mRNA can determine
gene product distribution and function in cells [22]. The 39 UTR
of hDMPK mRNA, when overexpressed, has been shown to be
detrimental to cardiomyocytes and myofibers [23]. We therefore
verified whether mitochondrial behavior differed between situa-
tions where hDMPK A protein was expressed from constructs with
or without its normal 39 UTR (Figure 1C and 1E), but found no
differences. Also, a control vector containing a YFP ORF followed
by the DMPK 39 UTR gave the anticipated cytosolic and nuclear
YFP distribution. Thus, our data indicate that the 39 UTR is not
involved in hDMPK A-induced mitochondrial clustering.
In most cell types where the DMPK gene is naturally expressed,
isoforms A and C are present in approximately equal amounts
[5,8, Mulders and Wansink, data not shown]. To test whether
presence of hDMPK C could prevent hDMPK A from inducing
mitochondrial clustering, we used N2A cells, well known for their
high transfection efficiency, to generate sufficient numbers of cells
that coexpressed hDMPK A and C in a double transfection.
Isoform hDMPK C failed to modulate formation of mitochondrial
clusters in all doubly transfected cells, indicating that hDMPK A
effects are dominant (Figure 1F).
Microtubule depolymerization reduces mitochondrial
clustering
The cytoskeleton controls interactions in the mitochondrial
network, facilitated by a host of membrane fission/fusion proteins,
motor and adaptor proteins. Mitochondria are transported along
microtubules and actin microfilaments [24]. Since hDMPK A
appears to affect mitochondrial dynamics and is also believed to
affect actomyosin behavior [6,7], we reasoned that its role could be
at the cytoskeletal-mitochondrial interface.
Comparison of the actin and microtubule cytoskeletons in cells
with YFP-hDMPK A or C expression did not reveal any overt
effect on structural integrity (Figure 2A and 2B). We also examined
what the absence of tubulin or actin filaments would do to the
perinuclear accumulation of mitochondria [25,26]. DMPK KO
mouse myoblasts [10] were reconstituted with hDMPK A or C
isoforms by adenoviral transduction and immediately treated with
cytochalasin D or nocodazole. F-actin depolymerization-disorga-
nization by cytochalasin D did not alter clustered mitochondrial
morphology as revealed by comparison between YFP-hDMPK
decoration patterns in A and C isoform-transfected cells
(Figure 2A). Also the frequency of clustering was not altered by
cytochalasin D treatment (measured as the percentage of
transfected cells that displayed clustered mitochondria;
Figure 2C). In contrast, in cells with a nocodazole-induced
microtubular disorganization, the fraction of hDMPK A-express-
ing cells displaying perinuclear accumulation of mitochondria was
significantly reduced, even though the fragmented appearance of
hDMPK A Clusters Mitochondria
PLoS ONE | www.plosone.org 2 November 2009 | Volume 4 | Issue 11 | e8024Figure 1. Perinuclear clustering of mitochondria is induced by the C-terminal domain of hDMPK A. (A,B) C2C12 myoblasts transiently
expressing YFP-hDMPK A or C fusion proteins or mock-transfected cells were stained with a cytochrome c oxidase antibody to visualize mitochondria.
Typical examples of classes of mitochondrial morphology are shown in (A). Mitochondrial distribution was classified as fragmented, clustered or
elongated. Frequencies of appearance are listed as percentage of the total number of cells expressing MOM-associated hDMPK A (n=3, ,50 cells
analyzed per experiment). Around 40% of YFP-hDMPK A-expressing cells showed a cytosolic expression. These cells contained mitochondria with a
typically elongated shape, but were disregarded in the analysis. (C) Schematic representation of YFP constructs used for transfection expression with
protein domains, mutations and 39 UTR indicated. (D) C2C12 myoblasts expressing YFP fusion proteins were stained with a cytochrome c oxidase
antibody to visualize their ability to induce clustering of mitochondria. (E) Expression of constructs with altered 39 UTRs demonstrated that the
hDMPK A 39 UTR was not involved in mitochondrial clustering. (F) Co-expression of YFP-hDMPK A and hDMPK C-HA in N2A cells resulted in
mitochondrial clustering, whereas cells only expressing hDMPK C-HA exhibited normal, elongated mitochondria. Bars, 10 mm.
doi:10.1371/journal.pone.0008024.g001
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nocodazole was washed out at 12–16 hours after transduction and
expression was continued for an additional 8 hours, the percent-
age of cells with mito-clusters was significantly higher than among
cells that were continuously treated with nocodazole (Figure 2D).
Nocodazole had no overt effect on mitochondrial location or
morphology in hDMPK C-expressing cells. To us, these
observations suggest that hDMPK A-induced fragmentation and
clustering are at least partly uncoupled effects and that
microtubular infrastructure only affects the extent of clustering.
Mitochondrial morphology changes soon after hDMPK A
translocation
To obtain insight in spatio-temporal aspects of mitochondrial
morphology alterations, KO myoblasts were transduced with
YFP-hDMPK isoforms and subjected to live imaging. Mitochon-
dria were visualized via MitoTracker Red staining and images
were taken every three minutes. YFP-hDMPK A located in the
cytosol at first appearance, but translocated and concentrated at
the MOM within four hours, after which fragmentation and
clustering of mitochondria occurred (Figure 3A). YFP-hDMPK C
Figure 2. An intact microtubular cytoskeleton enhances hDMPK A–induced perinuclear mitochondrial clustering. DMPK KO
myoblasts were transduced with YFP-hDMPK A or C-expressing adenoviruses in the presence of cytochalasin D (A) or nocodazole (B). F-actin was
visualized by fluorescent phalloidin. The microtubular cytoskeleton was stained with an anti-tubulin antibody. Disruption of the actin
cytoskeleton did not affect localization of mitochondria. Depolymerization of microtubules decreased mitochondrial clustering in YFP-hDMPK A-
expressing cells, but mitochondria still appeared fragmented. The distribution of mitochondria in YFP-hDMPK C-transduced cells was unaffected
by nocodazole treatment. Bars, 10 mm. (C) Quantification of mitochondrial clustering. The number of transduced cells that contain clustered
mitochondria are expressed as percentage of the total amount of cells expressing hDMPK A at the MOM, with or without treatment of
cytochalasin D or nocodazole (images shown in A and B; n=3, ,100 cells per experiment, P=0.01). (D) Effect of nocodazole wash-out.
Quantification of the percentage transduced cells with clustered mitochondria after a 12–16 hours treatment with nocodazole, followed by a
8 hours wash-out (n=3, ,30 cells per experiment, P,0.05).
doi:10.1371/journal.pone.0008024.g002
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drial clusters (Figure 3B). In transfected N2A cells, initial YFP-
hDMPK A staining in the cytosol was less evident and hDMPK A
appeared at the MOM without intermediate accumulation,
directly after expression onset. Size changes and clustering of
mitochondria could be detected as early as six hours after
transfection in these cells (Figure 3C). Combining these data with
findings in other cell lines [10] demonstrates that timing of
expression and sorting of DMPK isoforms may differ between cell
types, but the sequence of events that is induced once DMPK A is
associated with mitochondria is qualitatively similar.
Abnormal mitochondrial ultrastructure develops upon
hDMPK A expression
We performed electron microscopy (EM) on N2A cells
expressing hDMPK A to investigate effects on mitochondrial
ultrastructure and cell architecture. YFP-hDMPK A-transfected
cells were easy recognizable by the concentration of mitochondria
in the juxtanuclear region (Figure 4A), while other parts of the cell
were left completely void of mitochondria (Figure 4B). Clustered
mitochondria showed a rounded morphology, often with disorga-
nized or absent cristae structure and a decrease of electron density
in the matrix (Figure 4A). Cells with this appearance were never
seen in YFP-hDMPK C-transfected cultures. In control cells or
cells expressing YFP-hDMPK C mitochondria contained a
normal, intact cristae structure, were more elongated and had a
disperse localization (Figure 4C).
Besides abnormal mitochondria, we identified an increased
number of autophagic structures after hDMPK A expression
(Figure 4A). These autophagosomes varied in size and were found
near and within areas of clustered mitochondria. In some cases,
mitochondrial remnants could still be recognized, indicative of
mitophagy. The fraction of cells containing autophagic structures
was assessed by LM and EM and amounted to 12–14% after YFP-
hDMPK A expression and 5–6% in cells with YFP-hDMPK C.
As a second indicator of autophagy, we measured conversion of
LC3b protein using western blotting [27]. In transduced myoblasts
significant conversion to the LC3b-II form was observed after 16–
24 hours of expression of YFP-hDMPK A, but not C (Figure 4D).
These observations were confirmed in N2A cells (data not shown).
On blot, we repeatedly observed a reduced hDMPK A level within
the 16–24 h period of expression. We attribute this finding to a
selective loss of cells with highest DMPK A expression (see below).
Although this may have influenced our picture of kinetics of
autophagy induction in the entire pool of cells, our data
collectively point to a gradual viability loss in the majority of cells
in the transfected pool.
Clustering of mitochondria results in loss of function
Against this background, knowing that mitochondrial integrity
and function are dynamically linked and tightly coupled to the
cell’s physiological state [11,28], we investigated hDMPK A effects
on cell viability further. To force utilization of relevant metabolic
energy pathways, C2C12 myoblasts were kept in media of different
composition, including high or low oxygen supply, and monitored
after transfection with YFP-hDMPK A or C. Cell survival was
similar for YFP-hDMPK A-expressing cells growing under normal
conditions or high glucose conditions with low oxygen plus use of
mitochondrial uncoupler FCCP (to maximally prevent mitochon-
drial OXPHOS activity; Figure 5A). This outcome can be
explained because normal growth of cells in culture already
strongly relies on glycolytic metabolism [29] and therefore cannot
be further promoted. In glucose-deprived medium supplemented
with galactose, forcing cells to rely on mitochondrial oxidative
phosphorylation [30], hardly any YFP-hDMPK A-expressing cell
survived (Figure 5A). This suggests that clustering of mitochondria
is detrimental for cell viability, especially in aerobically-poised
situations when cells are forced to use mitochondrial TCA/
OXPHOS activity. As a control, YFP-hDMPK C-expressing cells
Figure 3. Mitochondrial clustering is a rapid process and occurs
already at low hDMPK A expression. KO myoblasts were
transduced with YFP-hDMPK fusion proteins (top panels), while
mitochondria stained with MitoTracker Red (bottom panels). Images
were collected every three minutes. The time of first appearance of YFP
signal was set at t=0; other time points are indicated in the top panels.
(A) YFP-hDMPK A was first detected in the cytoplasm. Soon YFP-
hDMPK–decorated mitochondria appeared which then started to
cluster, eventually resulting in severely aggregated mitochondria
surrounding the nucleus. (B) YFP-hDMPK C directly appeared on
mitochondria which maintained their elongated, reticular structure. (C)
In N2A cells, YFP-hDMPK A expression emerged in a similar fashion as in
KO myoblasts, except that mitochondrial clustering occurred almost
immediately and cytosolic staining was less pronounced.
doi:10.1371/journal.pone.0008024.g003
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conditions (Figure 5A).
Formation of an electrochemical proton gradient across the
inner mitochondrial membrane drives ATP production by
OXPHOS [31]. To compare possible effects of DMPK isoforms
on this coupling, we used staining of YFP-hDMPK A and C-
expressing HeLa cells with the fluorescent dye TMRM, which
provides a readout for the mitochondrial membrane potential
(MMP). HeLa cells were chosen because these have been used
before for MMP determination and gave sufficient TMRM signal
strength for quantitative analysis [32]. Before measurement,
depolarization with FCCP as described by Distelmaier et al.
[33] was used to control that TMRM accumulation did not
involve quenching, becoming a confounding factor in MMP
measurement. For many other cell lines the 100 nM TMRM
concentration appeared toxic or TMRM did not accumulate well
enough in mitochondria to generate adequate signals (data not
shown). YFP-hDMPK A-expressing HeLa cells showed a signif-
icantly lower MMP than cells that expressed YFP-hDMPK C
(Figure 5B and 5C). Interestingly, YFP-hDMPK A-positive cells
with no or only mild mitochondrial clustering showed a normal
MMP (Figure 5B, upper panels). The lack of signal in clustered
mitochondria could not be due to an inability to take up TMRM,
since they were able to internalize the related compound
MitoTracker Red (data not shown). The MMP in YFP-hDMPK
C-expressing cells was not significantly different from that in
untransfected cells (Figure 5C).
Cells with clustered mitochondria undergo apoptosis
We observed that YFP-hDMPK A-expressing KO myoblasts -
but not YFP-hDMPK C expressing cells - died rapidly after
prolonged periods of transfection-complementation and wondered
whether this loss could be explained by an apoptosis-based
mechanism. One finding supporting this conjecture was that
treatment with apoptosis inhibitor z-vad-fmk immediately after
transfection significantly increased the number of surviving
hDMPK A-expressing cells, whereas no effect was seen on the
viability of cells expressing hDMPK C (Figure 6A). Further
support was obtained by the observation that little or no staining of
cytochrome c, a mitochondrial intermembrane protein, was
present in clustered mitochondria in YFP-hDMPK A-expressing
KO myoblasts (Figure 6B, upper panels), while mitochondria that
were only fragmented did contain cytochrome c (Figure 6B,
middle panels). To us this suggests that release of cytochrome c, a
well known apoptosis-triggering event [34], probably occurs after
the onset of mitochondrial clustering. No cytochrome c release
was observed for YFP-hDMPK C-expressing cells (Figure 6B,
lower panels).
Figure 4. Mitochondrial clustering is accompanied by aberrant ultrastructural morphology. N2A cells were transfected with YFP-hDMPK
A or C isoforms and ultrastructure was analyzed by electron microscopy. (A) YFP-hDMPK A–expressing cells contained fragmented, clustered
mitochondria near the nucleus. Cristae structure was often partly lost together with electron density of the matrix (arrowhead) and mitophagy was
observed (arrow). In contrast, other areas of the cell were completely devoid of mitochondria (B). (C) Mitochondrial morphology was normal in
hDMPK C–expressing cells. A fragment of the nucleus is included here for orientation. Note the proper cristae structure and loose distribution of
mitochondria and endoplasmic reticulum. Bars, 1 mm. (D) Lysates from myoblasts expressing YFP-hDMPK A or C for 8, 16 or 24 hours were used for
western blotting with a LC3b antibody and showed an increased LC3b conversion following YFP-hDMPK A expression. Cells cultured under normal
conditions and nutrient-starved cells, cultured in Earle’s Balanced Salt Solution (EBSS) for 2 hours, were used as negative and positive controls,
respectively. DMPK expression was verified using a DMPK antibody. Tubulin (T) antibody staining was used as loading control.
doi:10.1371/journal.pone.0008024.g004
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We demonstrate here that expression of MOM-anchored
hDMPK A results in fragmentation of the mitochondrial network
and perinuclear clustering of morphologically-altered mitochon-
dria. In addition to these morphomechanical changes, physiolog-
ical changes like loss of MMP, increased autophagosomal activity
and leakage of cytochrome c accompanied by apoptosis were
induced. It is difficult to bring hierarchical ordering in these
events, but we propose that the fate of mitochondria in cells with
hDMPK A is specified as follows: based on our observations with
live-cell imaging and the finding that microtubule disruption
attenuated clustering, we suppose that induction of morphological
change is the initiating step that marks mitochondria for
subsequent anomalous transport and clustering. Upregulation of
autophagy may be an intermediate phase to rescue defective
energy and clear mitochondrial waste [35].
The fact that the same sequence of events in mitochondrial
fragmentation and perinuclear clustering with globally similar final
outcome occurred in all mouse and human cell types examined is
important. Slight variation in the speed and magnitude of events
was observed between cell types, but this can most easily be
explained by differences in cytoarchitectural arrangement, path-
ophysiological thresholds or stress-coping ability. Toxicity of
hDMPK A was also observed in KO myoblasts in which DMPK
was reconstituted to apparently normal expression levels by
complementation. We observed mitochondrial clustering already
after several hours of hDMPK A expression when ectopic protein
levels were still relatively moderate. Therefore, we postulate that
induction of abnormal mitochondrial behavior is an intrinsic
capacity of hDMPK A and cannot be simply explained as a result
of overexpression. Mutational analysis demonstrated that hDMPK
A’s tail region was sufficient to induce mitochondrial fragmenta-
tion and clustering. The conclusion that this is the only segment
with detrimental effects was corroborated by the observation that
MOM-binding of hDMPK C, which differs from hDMPK A only
in its C-terminus, had no effect on mitochondrial physiology and
trafficking.
Figure 5. Human DMPK A expression affects mitochondrial function and cell viability. (A) C2C12 myoblasts were grown under different
culture conditions and transfected with YFP-hDMPK A or C. The fraction of viable YFP positive cells was determined after 20 hours. When supplied
with galactose and pyruvate, YFP-hDMPK A-expressing cells showed a significantly lower viability than YFP-hDMPK C-expressing cells (P,0.01, n=3,
.100 cells analyzed per experiment). (B) The MMP was determined in HeLa cells expressing YFP-hDMPK A or C. YFP-hDMPK A–expressing cells
without clustered mitochondria showed a clear MMP signal (upper panels). No TMRM signal was found in YFP-hDMPK A–expressing cells with
clustered mitochondria (middle panels, asterisks). YFP-hDMPK C–expressing cells demonstrated a clear mitochondrial signal (lower panels). Bars,
10 mm. (C) The MMP in YFP-hDMPK A–expressing cells was almost completely abolished and significantly lower than in YFP-hDMPK C and non-
transfected (NT) cells (P,0.001, n=3, .35 cells per experiment).
doi:10.1371/journal.pone.0008024.g005
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effects induced by ectopic or overexpression of other MOM
proteins, like TA proteins hFis [15,36], Miro GTPases [37,38] and
Mfn 1 and 2 proteins [14,17,39]. All these enzymes are involved in
mitochondrial dynamics. Although similar in nature, changes
evoked by these MOM proteins cannot be simply lumped
together, since it is unclear how mitochondrial clustering occurs,
and clear mechanistic differences can be noted. For example,
enzymatic activity appears irrelevant for Mfn 1 and 2 [14,17,39]
and hDMPK A (this paper), but is necessary for hFis [36] and
Miro 1 and 2 [37]. We demonstrate that hDMPK A effects do not
require coiled-coil interactions between proteins, but Mfn 1 and 2
effects clearly rely on these associations [40]. The status of the
cytoskeleton does not determine Mfn 2 effects [14], yet hDMPK A
clustering partly depends on integrity of microtubules. It is
tempting to speculate that every distinct TA-containing MOM
protein has its own role in creating an appropriate microenviron-
ment for mitochondrial interactions with other cell structures.
Reactions mediated by these proteins may involve distinct areas in
the MOM and also the complex and diverse machinery that links
mitochondria to motor proteins may be differentially involved
[37,38,41,42]. Disbalance in any of these systems may create
overtly similar effects, with fragmentation and clustering of
mitochondria as main outcome.
Mitochondrial fragmentation and clustering is probably an
intrinsic property of the hDMPK A membrane anchor itself.
There is mounting evidence indicating that certain hydrophobic
regions in membrane proteins are able to induce membrane
curvature and remodeling. Our EM data demonstrate that
hDMPK A-decorated mitochondria are small and round - i.e.,
not one large continuum - suggesting that lipid-protein or lipid-
lipid interactions become abnormally affected in presence of the
tail anchor of hDMPK A. Direct effects of membrane anchors that
result in distortion of protein-protein interaction and clustering
followed by formation of abnormal membrane curvature, vesicle
formation or fragmentation have been described [43,44].
Coupling to abnormal fusogenic properties of hDMPK A’s anchor
could also be involved. It has been shown that Leu/Val residues
and Gly/Pro or Pro/Gly pairs in peptides in transmembrane
domains add to a high fusogenic index [45,46]. Exactly these
amino acids are highly abundant in the tail region of hDMPK A,
but not hDMPK C. Further knowledge about involvement of lipid
interactions with specific peptide sequences in hDMPK A’s tail
can be obtained by permutation analyses and biophysical
interaction studies. At this moment we can only remain speculative
about the importance of the amino acid composition of the
membrane anchor.
Many studies have shown that the physiological state of
mitochondria is reciprocally coupled to morphological appearance
[17,47]. Recently, even a relationship between mitochondrial form
and cell cycle control has been reported [48]. Although
mitochondrial fragmentation has been observed frequently in cells
undergoing apoptosis, its active role in apoptosis is still unclear
[36,49]. We observed that hDMPK A-induced morphological
effects ultimately lead to cell death and provide evidence that
cytochrome c leak did not occur and MMP was still largely intact
in hDMPK A-decorated mitochondria that were still in the
fragmented state. Loss of cytochrome c and disappearance of
MMP was observed when mitochondria became clustered. We
take these observations to indicate that events that occur during or
just before mitochondrial clustering must contribute to the onset of
apoptosis.
Aberrant mitochondrial morphology is linked to multiple
disease manifestations caused by mutations in genes involved in
fission and fusion, like Charcot-Marie-Tooth subtype 2A and
dominant optic atrophy [18,28]. Also in DM1 patient muscle,
mitochondrial irregularities have been found, although the cause
of these malformations has not yet been identified [19,20]. Studies
Figure 6. Expression of hDMPK A induces apoptosis. (A) The
effect of apoptosis-inhibitor z-vad-fmk was tested on cell survival of
DMPK KO myoblasts transduced with YFP-hDMPK A or C–expressing
adenoviruses. YFP-positive cells were counted after 16, 24, and
48 hours. Z-vad-fmk greatly reduced cell death of YFP-hDMPK A–
expressing cells, but had no effect when YFP-hDMPK C was expressed.
Z-vad-fmk was applied immediately after transduction and maintained
present for the remaining time of the experiment. Values at 16 hours
were set at 100% (P,0.05, n=3, .90 cells counted per experiment). (B)
YFP-hDMPK A and C–expressing cells were stained for cytochrome c
(cyt c). Cells expressing YFP-hDMPK A displayed a diffuse, cytosolic
cytochrome c staining when mitochondria were clustered (upper
panels). A clear mitochondrial staining was present when mitochondria
appeared fragmented (middle panels). A discrete, mitochondrial
cytochrome c staining was also observed in YFP-hDMPK C–expressing
cells. Bars, 10 mm.
doi:10.1371/journal.pone.0008024.g006
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isoforms especially in heart and skeletal muscle, showed disorga-
nized cristae structure and symptoms like reduced workload
tolerance, atrophy, hypertrophic cardiomyopathy, myotonic
myopathy and hypotension, reminiscent of DM1 symptoms [21].
We do not expect that the normal physiological function of
hDMPK is directly related to regulation of mitochondrial
clustering. Like hDMPK C, hDMPK A is predominantly
expressed in skeletal muscle myofibers [5,8], a cell type with a
rigidly compartmentalized cytoarchitectural infrastructure and
well-defined mitochondrial distribution across intramyofibrillar
and subsarcolemmal areas. This typical robust cytoarchitectural
organization may render muscle cells more resistant to fluctuations
in hDMPK A expression, but based on our findings we speculate
that also for myotubes it is of paramount importance that hDMPK
A protein levels are tightly regulated and strictly kept within the
normal physiological range. Expression levels of completely other
proteins, for example VEGF, also require tight regulation as both
reduced and increased expression can result in pathogenesis,
manifesting itself in embryonic lethality or cancer, respectively
[50]. Changes in DMPK mRNA synthesis or pre-mRNA splicing
induced by the presence of expanded (CUG)n transcripts, when
resulting in only a slight disbalance in hDMPK A expression level,
could thus be a contributing factor in the pathophysiology of DM
and explain mitochondrial abnormalities. In more extreme
situations like congenital DM with very large (CTG)n expansions,
where abnormal chromatin modification and defective bidirec-
tional transcriptional control across the DM locus may directly
couple to unbalanced DMPK production, the toxic effects of
DMPK A may even directly contribute to special disease features
[51,52]. Further research into the role of hDMPK A in health and
disease is thus warranted and also needed to validate this model
and its predictions. A more precise study of the balance in DMPK
splice isoforms in different categories of DM1 patients is a
necessary first step.
Materials and Methods
Antibodies and chemicals
Staining with anti-cytochrome c oxidase antibody [53] was used
to visualize mitochondria and monitor apoptosis. Monoclonal b-
tubulin antibody E7 (Developmental Studies Hybridoma Bank,
University of Iowa, Iowa City, Iowa) was used to stain the tubulin
cytoskeleton. TexasRed-conjugated-phalloidin staining (Molecular
Probes, Breda, The Netherlands) was used to visualize F-actin.
Manipulation of the cytoskeleton was performed by incubating
cells for 18 hours in cell culture medium supplemented with 3 mM
nocodazole (Sigma, Zwijndrecht, The Netherlands) or 0.6 mM
cytochalasin D (Sigma). Mouse monoclonal antibody 12CA5 was
used to detect the HA epitope tag. For western blotting DMPK-
specific antibody B79 [5], b-tubulin antibody E7 and LC3b
polyclonal antibody (Cell Signalling, Beverly, Massachusetts) were
used. Apoptosis was inhibited by addition of 100 mM of the pan-
caspase inhibitor z-vad-fmk (R&D systems, Abingdon, UK) to the
culture medium for 16–72 hours.
Cell culture and DNA transfection
C2C12 myoblasts (ATCC #CRL-1772), N2A neuroblastoma
cells (ATCC #CCL-131) and HeLa cells (ATCC #CCL-2) were
grown subconfluent in DMEM supplemented with 10% FCS and
maintained at 37uC under a 5% CO2 atmosphere. C2C12 and
N2A cells were transiently transfected with expression plasmids
(specified below) using Lipofectamine (Invitrogen, Breda, the
Netherlands) as specified by the manufacturer. HeLa cells were
transiently transfected using polyethyleneimine. After transfection
cells were maintained in culture for an additional 8–72 h prior to
analysis. Alternatively, we used adenoviral vector-based DNA
transduction for expression of single hDMPK isoforms in DMPK
knockout (KO) myoblasts [10], since transfection with lipofecta-
mine or polyethyleneimine does not achieve sufficient efficiency.
To force C2C12 myoblasts to use mitochondrial oxidative
phosphorylation for the production of ATP, cells were cultured in
DMEM without glucose, supplemented with 10 mM galactose,
1 mM sodium pyruvate, 2 mM glutamine and 10% dialyzed FCS.
Cells were maintained at 37uC under a 5% CO2 atmosphere. To
maximally stimulate glycolytic metabolism, C2C12 myoblasts were
cultured in DMEM, 10% FCS with 10 mM glucose and 1 mMo f
the mitochondrial uncoupler FCCP (Sigma, Zwijndrecht, The
Netherlands) and maintained at 37uC under a 2% O2 atmosphere.
Cells were allowed to adapt to these culture conditions for 5 days,
transfected with equal amounts of plasmid DNA encoding YFP-
hDMPK A or C and then maintained in culture for an additional
20 hours before the number of YFP-positive cells was analyzed.
Autophagy was induced by placing cells in nutrient-starvation
medium Earle’s Balanced Salt Solution (EBSS) for two hours.
Plasmids and adenoviral vectors for DMPK expression
EYFP-DMPK expression vectors were obtained by cloning
appropriate DMPK cDNA segments into pEYFP-C1 (Clontech,
Saint-Germain-en-Laye France) and pSG8DEco vectors [2,10].
Inserts of all expression plasmids were composed of relevant
domains from the open reading frames plus the adjacent 39 UTR
of DMPK cDNAs. All segments obtained via PCR were verified
by DNA sequencing.
MonoYFP-hDMPK A. To introduce a L221K mutation
into YFP, pEYFP-C1 vector was PCR-amplified with forward
primer 59-GATCACATGGTCCTTAAGGAGTTCGTGACC-39
and reverse primer 59- GGTCACGAACTCCTTAAGGAC-
CATGTGATC-39 (mutation underlined). The resulting fragment
was digested with BsrGIa n dNheI, gel purified and subcloned into
pEYFP-C1. A BglII excised hDMPK A fragment was introduced
into the BglII site.
YFP-hDMPK A
(K100A). A PCR fragment was amplified by
site-directed mutagenesis from a template pEYFP-hDMPK A
plasmid with forward primer 59- GGCCAGGTGTATGCC-
ATGGCAATCATGAACAAGTGGGAC-39 and reverse primer
59- GTCCCACTTGTTCATGATTGCCATGGCATACACCT-
GGCC -39 (mutation underlined). The resulting PCR product was
digested with BspEI and the fragment containing the mutation was
subcloned between two BspEI sites of pEYFP-hDMPK A.
YFP-hDMPK A
(534–629). A fragment encompassing human
tail 1 including the 39 UTR was PCR-amplified from pEYFP-
hDMPK A with forward primer 59-GGAAGATCTGCTG-
TCACGGGGGTCCC-39 adding a BglII site (underlined) and
reverse primer 59- TGCAATAAACAAGTTAACAACAAC-39
located in the multiple cloning site of the pEYFP-C1 backbone.
The resulting DNA was trimmed with BglII, gel purified and
subcloned into the polylinker of vector pEYFP-C1.
YFP-hDMPK A
(534–629)D39 UTR. A fragment encompassing
human tail 1 excluding the 39 UTR was PCR-amplified from
pEYFP-hDMPK A with forward primer 59-GGAAGATCTGC-
TGTCACGGGGGTCCC-39 adding a BglII site (underlined) and
reverse primer 59-CGAATTCTCAGGGAGCGCGGGCGG-39
located at the stop codon containing an EcoRI site (underlined).
The resulting DNA was trimmed with BglII and EcoRI, gel purified
a n ds u b c l o n e db e t w e e nt h eBglII and EcoRI restriction sites in the
polylinker of pEYFP-C1.
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UTR was PCR-amplified from pEYFP-hDMPK A, with forward
primer 59-GGAAGATCTTGAACCCTAGAACTGTCTTC-39
adding a BglII site (underlined) and reverse primer 59-
TGCAATAAACAAGTTAACAACAAC-39 located in the multiple
cloning site of the pEYFP-C1 backbone. The resulting DNA was
trimmed with BglII, gel purified and subcloned into the polylinker in
vector pEYFP-C1.
hDMPK C-HA. A fragment encompassing the final 900 bp of
the coding region of hDMPK C was amplified by PCR from
pEYFP-hDMPK C with forward primer 59-GCCGCTGGTGGA-
CGAAGGG-39 and reverse primer 59-GCCGGTACCTAAGCGT-
AATCTGGAACATCGTATGGGTAGGGTTCAGGGAGCGCGG-39
adding an HA tag (italics) and KpnI site (underlined). The PCR
fragment was trimmed with SstIa n dKpnI resulting in a 500 bp
fragment. A fragment of about 1.1 kb encompassing the 39 UTR of
hDMPK C was PCR amplified with forward primer 59-
GCCGGTACCTGAACCCTAGAACTGTCTTCG-39 adding a
KpnI site (underlined) and reverse primer 59-TGCAATAAACAA-
GTTAACAACAAC-39 located in the multiple cloning site of
pEYFP-C1. The PCR product was trimmed with KpnIa n dSalI
resulting in a 800 bp fragment. The two fragments were subcloned
into pEYFP-hDMPK C digested with SstIa n dSalI. The pEYFP-
hDMPK C-HA construct was digested with BglII and ligated into the
BglII sites of pSG8DEco resulting in pSG8DEco-hDMPK C-HA.
E1/E3-deleted serotype 5 adenoviral vectors encoding YFP-
hDMPK isoforms A and C under the control of a CMV IE-
promoter were generated using the AdEasy Vector System [54], as
described [55]. In brief, cDNAs encoding YFP-hDMPK isoforms
including their 39-UTR, were obtained from pEYFP-hDMPK A
or C and cloned into transfer vector pShuttle-CMV. In a second
step, pShuttle-YFP-hDMPK plasmid was recombined with the
viral DNA plasmid pAdEasy-1 in E. Coli strain BJ5183. Next, viral
particles were generated in N52.E6 [56] viral packaging cells [57].
Adenoviral vectors were purified using CsCl gradient purification
and stored at 280uC. The viral titer and plaque forming units
were determined [55].
Immunofluorescence microscopy
Cells were grown on glass coverslips, fixed in PBS containing
2% (w/v) formaldehyde ,20 h after transfection and permeabi-
lized in PBS containing 0.5% (w/v) Nonidet P-40 substitute.
Samples were processed for immunofluorescence microscopy
using standard procedures. Images were obtained with a Bio-
Rad MRC1024 confocal laser scanning microscope (Biorad,
Hercules, California) equipped with an argon/krypton laser, using
a 60x 1.4 NA oil objective and LaserSharp2000 acquisition
software.
Time-lapse imaging
Transfected KO myoblasts or N2A cells were stained for 30
minutes using 1 mM MitoTracker Red (CM-H2XROS; Invitro-
gen). After washing with acquisition medium (DMEM without
phenol red supplemented with 10% (N2A) or 20% FCS (KO
myoblasts)), dishes were mounted into a temperature-controlled
incubation chamber on the stage of an inverted microscope
(Axiovert 200 M; Carl Zeiss, Jena, Germany) equipped with a 63x,
1.25 NA Plan NeoFluar oil-immersion objective. Images were
acquired every three minutes in three Z-directions at 33uC for
myoblasts and 37uC for N2A cells during which cells were
maintained in standard culture medium without phenol red. YFP
was excited at 510 nm with an acquisition/illumination time of
200 ms and fluorescence light was directed through a 545AF35
emission filter (Omega Optical, Brattleboro, VT). MitoTrack-
erRed was excited at 568 nm (Polychrome IV) with an
acquisition/illumination time of 200 ms and fluorescence light
was directed by a 525DRLP dichroic mirror (Omega) through a
564AF65 emission filter (Omega). A CoolSNAP HQ monochrome
CCD-camera (Roper Scientific Photometrics, Vianen, The
Netherlands) was used and no bleed through was detected.
Hardware was controlled by and images were analyzed using
Metamorph 6.2 software for mean fluorescence intensity of the
mitochondrial area.
Western blotting
Cells were lysed on ice in NP40 lysis buffer (1% NP40, 50 mM
Tris-HCl, pH 7.5, 150 mM NaCl, 25 mM NaF, 1 mM sodium
pyrophosphate, 0.1 mM vanadate, 1 mM PMSF, 1x protease
inhibitor cocktail (Roche, Mannheim, Germany), 1 mM EDTA).
Lysates were cleared by centrifugation for 10 min at 14,000 g at
4uC and supernatant fractions were mixed with SDS-PAGE
sample buffer. Lysates were separated on 8% SDS-PAGE gels and
transferred by western blotting to PVDF membrane. As secondary
antibody, HRP-conjugated IgG (Jackson ImmunoResearch Lab-
oratories, UK) was used, and signals were generated by ECL,
followed by exposure to film (Kodak X-OMAT AR).
Mitochondrial membrane potential (MMP)
HeLa cells were cultured in Willco dishes (Willco wells B.V.,
Amsterdam, The Netherlands) and transfected with pEYFP-
hDMPK A and pEYFP-hDMPK C. After ,20 h, cells were
stained for 30 minutes using tetramethylrhodamine methyl ester
TMRM (Invitrogen) at 100 nM in DMEM supplemented with
10% FCS. Wilco dishes were mounted on the stage of the inverted
microscope. Experiments were performed at room temperature
during which cells were maintained in phenol red-free DMEM
supplemented with 10% FCS. TMRM was excited at 555 nm with
an acquisition/illumination time of 100 ms using a monochroma-
tor (Polychrome IV, TILL Photonics, Gra ¨felfing, Germany) and
fluorescence light was directed by a 560DRLP dichroic mirror
(Omega) through a 565ALP emission filter (Omega) and detected
as above. YFP was excited at 470 nm (Polychrome IV) with an
acquisition/illumination time of 100 ms and fluorescence light was
directed by a 505DRLPXR dichroic mirror (Omega) through a
565ALP emission filter. No bleed-through was detected. All
hardware was controlled using Metafluor 6.0 software (Molecular
Devices Corporation, Downingtown, PA). Images were analyzed
using Metamorph 6.2 software for mean fluorescence intensity of
the mitochondrial area [58].
Electron microscopy
Cells were fixed in 2% glutaraldehyde in 0.1 M cacodylate
buffer and post-fixed for 1 h in 1% osmium tetroxide and 1%
potassium ferrocyanide in 0.1 M cacodylate buffer. After washing
in buffer, cells were dehydrated in an ascending series of aqueous
ethanol and transferred via a mixture of ethanol and Epon to pure
Epon 812 as embedding medium. Ultrathin sections (60–80 nm)
were cut, contrasted with aqueous 3% uranyl acetate, rinsed, and
counterstained with lead citrate, air dried, and examined in a
JEOL JEM1010 electron microscope (JEOL, Welwyn Garden
City, UK) operating at 80 kV.
Autophagosome quantification by LM and EM
Samples were fixed and embedded as described for EM
analysis. 1% osmium tetroxide was included to increase visibility
of membranes [59]. Sections of 0.5 mm were cut and stained with
toluidine blue. Sections were mounted on a cover glass using
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Leica DM6000B/CTR6000 imaging system and Leica IM500
Image Manager acquisition software (Leica, Solms, Germany).
The percentage of cells containing one or more spheroid
autophagosome structures was quantified. Quantification on
ultrathin sections by electron microscopy was done in a similar
manner.
Statistics
Data are expressed as mean 6 s.e.m. Between group
comparison was performed by two-tailed unpaired Student’s t-
test. Differences between groups were considered significant when
P,0.05. * P,0.05, ** P,0.01, *** P,0.001. Statistical analyses
were performed with GraphPad Prism 4 software. The number of
replicates and the number of cells counted per experiment are
described in the figure legends.
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